T0	Outcomes 872 940	using efficacy results from the EEC, IgG responses, and tolerability
T1	Outcomes 1008 1009	.
T2	Outcomes 1010 1033	The total symptom score
T3	Outcomes 1245 1252	320 Î¼g)
T4	Outcomes 1347 1386	were well tolerated, no serious adverse
T5	Outcomes 1393 1425	occurred; two Grade II reactions